Orthofix Medical Inc. (OFIX)

13,60 +0,36 (+2,72%) Alla chiusura: 04:00PM EDT

Orthofix Medical Inc.

3451 Plano Parkway
Lewisville, TX 75056
United States
214 937 2000
https://www.orthofix.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 1.634

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Ms. Kimberley A. Elting	President of Global Orthopedics	1,15M	N/D	1965
Mr. Geoffrey C. Gillespie	VP & Corporate Controller	402,48k	N/D	N/D
Mr. Massimo Calafiore	President, CEO, Director and Interim President of Global Spine	N/D	N/D	1972
Ms. Julie B. Andrews	Chief Financial Officer	N/D	N/D	1971
Mr. Roberto Donadello	Senior Vice President of Global Operations	N/D	N/D	N/D
Mr. Dan E. Yarbrough	Vice President of Investor Relations	N/D	N/D	N/D
Ms. Jill Mason	Interim Chief Ethics & Compliance Officer and VP of Corporate Counsel	N/D	N/D	N/D
Mr. J. Andres Cedron	Chief Legal Officer & Corporate Secretary	N/D	N/D	1981
Mr. Lucas S. Vitale	Chief People & Business Operations Officer	N/D	N/D	1976
Mr. Ehab M. Esmail	Senior Vice President of Global Quality, Regulatory & Clinical Affairs	N/D	N/D	1972

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Governance aziendale

L'ISS Governance QualityScore di Orthofix Medical Inc. al 1 maggio 2024 è 3. I criteri di valutazione fondamentali sono revisione: 6; Consiglio di Amministrazione: 5; diritti degli azionisti: 1; retribuzione: 2.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.